MicroRNA 8089 (MIR8089)

MicroRNA 8089 (MIR8089) is a predicted human microRNA belonging to the class of small (20–24 nucleotide) non-coding RNAs that regulate gene expression primarily through binding to complementary sequences in the 3' untranslated regions of messenger RNAs, leading to mRNA destabilization or translational inhibition[1]. MicroRNAs are generated from longer primary transcripts by sequential cleavage with Drosha and Dicer ribonucleases and act as components of the RNA-induced silencing complex (RISC)[1][5]. As of now, there is no evidence that MIR8089 is a validated therapeutic target, nor has it been associated with specific drugs, diseases, or clinically relevant biomarkers[1]. It is not listed among functionally characterized regulatory microRNAs in the literature or major cancer biomarker panels[2][3]. The gene’s presence in databases like GeneCards indicates it is a computationally predicted (not experimentally validated or characterized) microRNA[1]. Standard entries for miRNAs (including MIR8089) cover general functions and processing but lack specific data for this particular microRNA.

Other names

hsa-mir-8089microRNA mir-8089MIR8089